First launched only about a year and a half ago in June 2019, preprint server medRxiv has enjoyed a super-sharp uptick in the number of manuscripts posted since February 2020, largely due to COVID-19 related submissions. medRxiv is not a journal publication or journal publisher – rather it is a preprint server or outlet for “the distribution of preprints that are complete but unpublished manuscripts describing health research”.

The pandemic has certainly put preprints on the fast-track to acceptance by the clinical research community, despite the fact that they are “preliminary reports of work that have not been certified by peer review”. As part of their COVID-19 response, the National Library of Medicine took the lead among database service providers and made the rather significant decision to index COVID-19 related preprints from specific preprint servers in PubMed, thereby enhancing their discoverability (and potential citations in new research) further.

That said – the debate about the benefits/challenges of preprints in the health sciences is still ongoing. However, it is becoming clear that preprints can no longer be ignored.

For a nice overview of where things stand with medRxiv (and other preprint servers) and where they may headed, be sure to check out the November 10, 2020 issue of JAMA, which includes these noteworthy papers:

Krumholz HM, Bloom T, Sever R, Rawlinson C, Inglis JR, Ross JS. Submissions and Downloads of Preprints in the First Year of medRxiv. JAMA. 2020;324(18):1903–1905. doi:10.1001/jama.2020.17529 

Flanagin A, Fontanarosa PB, Bauchner H. Preprints Involving Medical Research—Do the Benefits Outweigh the Challenges? JAMA. 2020;324(18):1840–1843. doi:10.1001/jama.2020.20674

Malički M, Jerončić A, ter Riet G, et al. Preprint Servers’ Policies, Submission Requirements, and Transparency in Reporting and Research Integrity Recommendations. JAMA. 2020;324(18):1901–1903. doi:10.1001/jama.2020.17195 

For more information on preprints – be sure to Ask Us at the MSK Library!